APPlexus Spring 2025

APPlexus is an initiative designed to address educational needs specific to advanced practice providers who care for patients with cancer. The materials provided on this page will navigate insights and updates for CAR T-cell therapy for hematologic malignancies, managing adverse events of immune checkpoint inhibitors used alone and in combination with chemotherapy and targeted therapies, and review novel antibody–drug conjugates as treatments for breast cancer, while delivering innovative, real-time education to nurse practitioners, nurses, physician associates, and other healthcare professionals who care for these patients. The program features expert-written ClinicalThoughts and on-demand webcasts, complete with downloadable slide decks for practical application.

Share

Program Content

Events

Live Event APPlexus Spring 2025: Clinic-Ready Insights on Emerging Data for Current Antibody–Drug Conjugates in Breast Cancer
APPlexus Spring 2025: Clinic-Ready Insights on Emerging Data for Current Antibody–Drug Conjugates in Breast Cancer
Congratulations: You achieved a completion on 04/09/2022

You can enroll in the following live event(s) on this topic.

Activities

Breast Cancer ADC Essentials
Background on the Targets, Structures, and Mechanisms of ADCs Approved for Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 13, 2025

Expires: September 12, 2025

Latest Evidence With the Breast Cancer ADCs
Current ADC Indications and Data From Clinical Trials and Real-World Cohorts
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 13, 2025

Expires: September 12, 2025

Breast Cancer ADC Safety Considerations
Optimizing Safety and Quality of Life in Patients Receiving ADCs for Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 14, 2025

Expires: September 13, 2025

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Clinical Care Options, LLC (CCO) and Practicing Clinicians Exchange (PCE).

Supporters

Advances in CAR T-Cell Therapy for Patients With Hematologic Malignancies

Supported by an educational grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Strengthening the Safety Net With Advanced Nursing Strategies for Managing Immunotherapy-Related Adverse Events

Supported by educational grants from Bristol Myers Squibb and Merck Sharp & Dohme LLC.

Clinic-Ready Insights on Emerging Data for Current Antibody–Drug Conjugates in Breast Cancer

This program has been supported by an independent educational grant from Gilead Sciences, Inc.

Bristol Myers Squibb

Gilead Sciences, Inc.

Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC

Merck Sharp & Dohme, LLC

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner